HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

Haleon's Nick Tate: Tech Partnerships Key To Unlocking Digital Consumer Health Future

“There’s no one company, government, person or technology who is positioned to ‘solve’ the health of the world,” notes Haleon's Nick Tate. Which is why OTC companies are partnering with tech firms large and small to create the next generation of consumer healthcare products and services. In the first part of an exclusive interview on the future of digital consumer health, Tate – who heads up the firm’s incubator business, Haleon NEXT – discusses some of the complications of tech innovation that make such collaboration attractive.

United Kingdom Health Wellness

CIR Panel’s ‘Ethereal’ Role In Cosmetics Regulation Not Clarified By MoCRA

Legislation Cosmetic Ingredients Safety

P&G Looks To Change Children’s Toothpaste Market With Crest Kids Color Changing

Latest Articles

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Health And Wellness Weekly Trademarks Review: 21 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks

US OTC Monograph Drug Facility Fees Up 8%, Higher Price Tags Stuck On OMORs, Too

FY2023 OTC monograph user fee target facility fee revenue is $25.4m from manufacturers’ fees of $26,153 and contract manufacturers’ fees of $17,435, all due by 1 June. OMOR fees are $517,381 for Tier 1 requests and $103,476 for Tier 2.

User Fees OTC Drugs

People On The Move: Appointments At GSCF, Bayer, Shop Apotheke

A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.

Executive Changes Leadership

‘Stop Fighting' US FDA On Inspections As Food Safety Overhaul Brings ‘Big Change’ To Drug Systems – Califf

Commissioner Califf underscores need to keep inspections systems ‘tuned up’ to prevent manufacturers from ‘losing their edge’ on quality.

OTC Drugs Regulation

Errors Coughed Up For Dextromethorphan, Guaifenesin In US FDA Electronic Registrations

Three of seven businesses warned since February 2022 about noncompliance with FDA drug reporting requirements have been marketers of OTC cough/cold/congestion formulations made with dextromethorphan or guaifenesin.

FDA OTC Drugs

Haleon’s Tess Player: Digital Self-Care Can Reduce Health Inequality And Raise Productivity

Haleon's partnership with Microsoft to include 1,500 of the former's products in the latter's Seeing AI application  which reads aloud information on packs for the visually impaired  is an example of how digitalization can help to make healthcare more inclusive, according to vice president and global head of healthcare professionals and health influencer marketing Tess Player.

International Health
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

Revlon Sees Light Through Bankruptcy Tunnel, Expects to Emerge In April

New York-based Revlon, Inc. expects to emerge from Chapter 11 bankruptcy after a 3 April meeting with the Bankruptcy Court for the Southern District of New York. The firm says it has settled with a group of unsecured creditors and agreed to financial restructuring that should reduce total debt burden by about $2.7bn.

Business Strategies Sales & Earnings

NAD: Advertisers Must Substantiate Unpaid, Third-Party Claims Once They Link To Or Disseminate Them

Texas-based hair care marketer Routine Wellness must substantiate an unpaid, third-party lifestyle blog’s review claiming the brand’s product is among the ‘5 best shampoos for women with thin hair’ because it linked to the review from its own social media pages, says the National Advertising Division in a review published 2 March.

Advertising, Marketing & Sales Regulation

Cosmetic And Personal Care Weekly Trademarks Review: 21 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

Ulta: Beauty Market’s ‘Unprecedented’ Growth Reflects New Trends, Not Just Pandemic Rebound

Growth over the last two years reflects new market dynamics and a growing connection between beauty and wellness, in addition to a return to sales following pandemic-related shutdowns, Ulta Beauty leaders said in a fourth-quarter sales and earnings presentation.

United States Outlook 2023

Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later

Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.

FDA Regulation

Cosmetic And Personal Care Weekly Trademarks Review: 14 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Health And Wellness Weekly Trademarks Review: 21 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks

US FDA Supplement Facility Inspection Numbers Back To Typical Along With GMP Problems Found

Supplement facility GMP inspections by FDA in 2022 along with the frequency of form 483s sent to firms following inspections return to roughly pre-pandemic annual numbers after dipping during 2020 and 2021.

Dietary Supplements FDA

People On The Move: Appointments At GSCF, Bayer, Shop Apotheke

A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.

Executive Changes Leadership

‘Stop Fighting' US FDA On Inspections As Food Safety Overhaul Brings ‘Big Change’ To Drug Systems – Califf

Commissioner Califf underscores need to keep inspections systems ‘tuned up’ to prevent manufacturers from ‘losing their edge’ on quality.

OTC Drugs Regulation

US FDA’s Infant Formula Regulatory Authority Doesn’t Reach ‘All That Needs To Be Fixed’

“This system is fundamentally prone to supply chain disruptions with so few manufacturers,” says Mark Moorman, FDA Office of Food Safety director. In FDLI presentation, he acknowledges delicate balance in stemming distribution of potentially contaminated power formula while sustaining supply.

Consumer FDA

German Nutraceuticals Market Growth Slows In 2022 But Vitamin C Remains Popular

The growth of sales of nutraceuticals through German pharmacy is slowing post-pandemic, according to IQVIA data. However, there were still double-digit gains for vitamin C and multivitamin products.

Germany Wellness
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

German Nutraceuticals Market Growth Slows In 2022 But Vitamin C Remains Popular

The growth of sales of nutraceuticals through German pharmacy is slowing post-pandemic, according to IQVIA data. However, there were still double-digit gains for vitamin C and multivitamin products.

Germany Wellness

Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla

In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of global consulting services, Amit Shukla, to find out how the global consumer healthcare market is performing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to expand by 5-6% per year in the future - even faster if some of the innovative switches currently in the pipeline succeed. Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.

Health International

From Probiotics To Prebiotics, Postbiotics and Synbiotics – The IPA Expands Its Scope

The International Probiotics Association has expanded its remit to include prebiotics, postbiotics and synbiotics – combinations of pre- and probiotics. HBW Insight asks the IPA's executive director George Paraskevakos what this means for the consumer healthcare industry and what the future of the microbiome-based wellness market might hold. 

International Wellness
See All
UsernamePublicRestriction

Register